Randomized controlled trials (RCTs) form a cornerstone of oncology research by generating
evidence about the efficacy of therapies in selected patient populations. However, their …

The older population consisting of persons aged 65 years or older is the fastest-growing
population group and also the major consumer of pharmaceutical products. Due to the …

Importance Although older patients are at increased risk of developing grade 3 or higher
chemotherapy-related toxic effects, no studies, to our knowledge, have focused on the …

Geriatric assessment (GA) has been shown to decrease toxicity from systemic therapy,
improve completion of chemotherapy, and reduce hospitalizations in older adults with …

Objective Five commonly used global health assessment tools have been evaluated to
identify and assess the preoperative frailty status and its relationship with perioperative in …

New treatment strategies have improved survival of metastatic colorectal cancer in trials.
However, it is not clear whether older patients benefit from these novel therapies, as they are …

Older cancer patients are disproportionally affected by the Coronavirus 19 (COVID-19)
pandemic. A higher rate of death among the elderly and the potential for long-term disability …

Background While adherence to cancer prevention recommendations is linked to lower risk
of colorectal cancer (CRC), few have studied associations across the entire spectrum of …

Treating older adults with cancer is increasingly important in modern oncology practice.
However, we currently lack the high-quality evidence needed to guide optimal management …

Purpose To evaluate whether adjuvant radiotherapy (RT) following breast-conserving
surgery (BCS) results in better survival among women≥ 70 years with T1-2N0 estrogen …